reuters.com
Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial
A two-in-one mRNA vaccine developed by Moderna that targets seasonal influenza and COVID-19 produced robust and durable immune responses without safety concerns in a small mid-stage trial, the company...
